Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will release its first quarter 2024 financial results and operational highlights before open of US markets on Tuesday, May 14, 2024.
伦敦，2024年4月23日（环球新闻专线）——开发下一代程序化T细胞疗法的临床阶段生物制药公司Autolus Therapeutics plc（纳斯达克股票代码：AUTL）今天宣布，将在2024年5月14日星期二美国市场开盘前发布其2024年第一季度财务业绩和运营摘要。
Management will host a conference call and webcast at 8:30 am EDT/1:30 pm BST to discuss the company's financial results and provide a general business update. Conference call participants should pre-register using this link to receive the dial-in numbers and a personal PIN, which are required to access the conference call.
管理层将在美国东部夏令时间上午 8:30 /英国夏令时间下午 1:30 主持电话会议和网络直播，讨论公司的财务业绩并提供总体业务最新情况。电话会议参与者应使用此链接进行预注册，以接收拨入号码和个人 PIN，这是访问电话会议所必需的。
A simultaneous audio webcast and replay will be accessible on the events section of Autolus' website.
Autolus 网站的 “活动” 部分将提供同步的网络音频直播和重播。
Contact:
联系人：
Olivia Manser
+44 (0) 7780 471568
o.manser@autolus.com
奥利维亚·曼瑟
+44 (0) 7780 471568
o.manser@autolus.com
Julia Wilson
+44 (0) 7818 430877
j.wilson@autolus.com
朱莉娅威尔逊
+44 (0) 7818 430877
j.wilson@autolus.com
Susan A. Noonan
S.A. Noonan Communications
+1-917-513-5303
susan@sanoonan.com
苏珊·努南
S.A. Noonan 通讯
+1-917-513-5303
susan@sanoonan.com